Noom: Noom launches full-page ad in Wall Street Journal advocating for policy changes regarding compounded GLP-1s
Noom wants the FDA to change its guidance on compounded drugs to factor in costs, in addition to shortages.
Read full article »
Noom is a New York-based digital health platform that offers weight loss management and dieting programs for individuals.
Read more